Seqster's Ardy Arianpour on tackling digital health interoperability and how his company applies a person-centric approach to empowering patients
GlaxoSmithKline's Kai Gait speaks to the pharmaphorum podcast about digital disruption and innovation in healthcare
bluebird bio’s UK general manager Nicola Redfern on gene therapy market access and Brexit’s impact on UK biotech
OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes
In the digital age, the technology exists to better capture, analyse and share healthcare data to drive better patient outcomes, to improve their quality of life and ultimately to analyse aggregated, anonymised data to enhance our understanding of disease and population level outcomes.
Online patient communities are now a staple of the healthcare landscape, giving the sector greater opportunities to understand and tackle unmet need. What can pharma learn from these peer support groups?
pharmaphorum has produced a special edition of its Deep Dive digital magazine that’s dedicated to digital health innovation.
Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines. Richard Staines looks at the progress already made thanks to this potentially revolutionary technology, and how it could change the fortunes of a beleaguered pharma industry
Australia continues to show the world how not to implement an electronic health records system, after health minister Greg Hunt extended the deadline for opting out.
This webinar examines digital transformation - how it has long been a priority for all life science companies and is now even more pressing as a result of the COVID-19 health emergency
Paul Tunnah spoke with Otsuka Pharmaceutical’s Kabir Nath about the company’s digital collaboration with Proteus and its ‘digital pill’
Our new patient-centric world has already gone “beyond the pill”, and now it’s going beyond the patient. Time to support the support network.
Ahead of the eyeforpharma Awards we spoke to judge Jennifer Wong – AstraZeneca’s senior director, RWE strategy & alliances, global medical affairs – about why collaboration and RWE the key to a digital future for pharma
We spoke to Jeanne Barnett, founder of CysticFibrosis.com and blockchain advocate, about this potential new paradigm for clinical research
How pharma can break through multi-device media clutter
People living with chronic conditions remain cautious
What does it mean to play an active role in treatment?
Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company’s strategy encompassing both immune oncology and inflammatory diseases
TRACON Pharmaceuticals' president and CEO Charles Theuer on changes in oncology and cancer trials, and how his firm is keeping pace
We speak to Sandoz’s global head of biopharmaceuticals, Stefan Hendriks, about the remaining challenges in market access for biosimilars
